Evommune to present phase 2a atopic dermatitis data at EADV
Evommune to present phase 2a atopic dermatitis data at EADV
Profit by knowlytics
Uncover the latest corporate headlines, economic policies, macro-level market updates, and industry developments shaping Indian and global markets on FinSiddhi.
Evommune to present phase 2a atopic dermatitis data at EADV
AIR Limited prices $425 million senior notes at 7.875%
Saratoga Investment prices $20.08M notes offering at 8%
Capitol Federal Financial names Skrobacz as president
Mineralys to present lorundrostat trial data at AHA meeting
<a href=”https://timesofindia.indiatimes.com/india/tap-water-on-paper-no-proper-accounts-says-jk-probe-panel/articleshow/134445471.cms”><img border=”0″ hspace=”10″ align=”left” style=”margin-top:3px;margin-right:5px;” src=”https://timesofindia.indiatimes.com/photo/134445471.cms” /></a>
Stoke Therapeutics appoints Bo Cumbo to board of directors
AerCap subsidiary prices $1.5 billion senior notes offering
Nasdaq ends over 1% lower as surging yields weigh on tech; Trump-Xi meeting eyed
Form 4 Yorkville America Investment Trust For: 23 September